Kerydin Approval History

  • FDA approved: Yes (First approved July 7th, 2014)
  • Brand name: Kerydin
  • Generic name: tavaborole
  • Company: Anacor Pharmaceuticals
  • Treatment for: Onychomycosis, Toenail

Kerydin (tavaborole) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails.

FDA Approval History for Kerydin

DateArticle
Jul  8, 2014Approval FDA Approves Kerydin (tavaborole) Topical Solution for Onychomycosis of the Toenails
Oct  3, 2013Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Jul 29, 2013Anacor Pharmaceuticals Announces That It Has Submitted a New Drug Application to the FDA for Tavaborole

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)